Tai Sandi See, Chief Development Officer: Lexeo Therapeutics LXEO Sell · Filed 25/11/20

Trade details

Type: Insider sale
Amount: $3,578.22
Shares · price: 386 sh · $9.27 a share
Held after: 65,476 sh
Stock: Lexeo Therapeutics LXEO
Person: Tai Sandi SeeChief Development Officer
Trade date: 25/11/18
Filed: 25/11/20
Days to filing: 2 days

Sold 0.6% of holdings

Share of holding sold: 0.6%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/19~25/12/18

Tai Sandi See's recent trades

Tai Sandi SeeChief Development Officer
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$24.7K
3,861 sh
$24.7K
Filed 02/18
Traded 02/18
Tai Sandi SeeChief Development Officer
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$3,580
386 sh
$3,580
Filed 25/11/18
Traded 25/11/18
Tai Sandi SeeChief Development Officer
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$34.4K
3,844 sh
$34.4K
Filed 25/10/17
Traded 25/10/17
Tai Sandi SeeChief Development Officer
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$421
44 sh
$421
Filed 25/10/17
Traded 25/10/17
Tai Sandi SeeChief Development Officer
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$34.8K
3,888 sh
$34.8K
Filed 25/10/17
Traded 25/10/17